Sign In
Buy PURE
$0.0640
-0.0010 (-1.54%)
At Close: Jul 31, 2026
PURE Bioscience Announces Distribution Agreement with AFCO, a Zep Company
09:00am, Wednesday, 20'th Nov 2024
EL CAJON, Calif.--(BUSINESS WIRE)-- #AFCO--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrob
PURE Bioscience Announces Distribution Agreement with Quip Laboratories
09:00am, Friday, 01'st Nov 2024
EL CAJON, Calif.--(BUSINESS WIRE)-- #AALAS--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicro
PURE Bioscience Reports Fiscal 2024 Financial Results
04:05pm, Tuesday, 29'th Oct 2024
EL CAJON, Calif.--(BUSINESS WIRE)-- #Biofilm--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimic
PURE Bioscience Announces Distribution Agreement with Madison Chemical Co., Inc.
01:00pm, Tuesday, 22'nd Oct 2024
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) a
PURE Bioscience Announces Distribution Agreement with Zee Company
09:00am, Wednesday, 09'th Oct 2024
EL CAJON, Calif.--(BUSINESS WIRE)-- #Biofilm--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), has entered into a multi-year distribution agreement with Tennessee-based
PURE Bioscience Announces Distribution Agreement with ChemStation
02:02pm, Thursday, 01'st Aug 2024
EL CAJON, Calif.--(BUSINESS WIRE)-- #Biofilm--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimic
PURE Bioscience to Unveil its Newest Food Safety Solutions at the Annual International Association for Food Protection Meeting
11:00am, Tuesday, 02'nd Jul 2024
EL CAJON, Calif.--(BUSINESS WIRE)-- #Biofilm--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, is set to unveil its newest food saf
PURE Bioscience Announces an International Supply and License Agreement with AgroVet Alliance
09:30am, Tuesday, 18'th Jun 2024
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and
PURE Bioscience Reports Fiscal Third Quarter 2024 Financial Results
04:05pm, Friday, 14'th Jun 2024
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, tod
PURE Bioscience Appoints Darin Zehr to Board of Directors
01:00pm, Monday, 06'th May 2024
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, tod
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
04:05pm, Monday, 18'th Mar 2024
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, tod
PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results
04:02pm, Thursday, 14'th Dec 2023
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, tod
PURE Bioscience Reports Fiscal 2023 Financial Results
04:05pm, Monday, 30'th Oct 2023
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, tod
PURE Bioscience Reports Fiscal First Quarter 2022 Financial Results
09:05pm, Wednesday, 15'th Dec 2021 Business Wire
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (the Company, PURE or we), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2021. Summary of Results Fiscal First Quarter Operations Net product sales were $497,000 and $1,417,000 for the fiscal first quarters ended October 31, 2021 and 2020, respectively. The decrease of $920,000 was attributable t
PURE Bioscience Reports Fiscal 2021 Third Quarter and Nine-Month Financial Results
04:05pm, Tuesday, 15'th Jun 2021
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrob
